Skip to main content
Clinical Trials/CTRI/2024/04/066132
CTRI/2024/04/066132
Not yet recruiting
Phase 3

A randomised controlled trial to compare the efficacy of carbetocin vs oxytocin in preventing postpartum hemorrhage in women undergoing vaginal delivery - Nil

Esther Issac0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Esther Issac
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Esther Issac

Eligibility Criteria

Inclusion Criteria

  • Singleton pregnancies
  • Undergoing vaginal delivery

Exclusion Criteria

  • Patients with one or more of following were excluded:
  • underlying medical disease, including severe pre\-eclampsia, eclampsia,bleeding disorders, thrombocytopenia, cardiovascular diseases, liver and renal diseases.
  • (2\) history of oxytocin or carbetocin allergy
  • (3\) obstetric complications, such as placental abruption and abnormal placentation.

Outcomes

Primary Outcomes

Not specified

Similar Trials